The average life expectancy of people diagnosed with dementia ranges from 9 years at age 60 to 4.5 years at age 85 for women ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer’s disease in older adults.

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

With announcements on new Alzheimer's drugs, the launch of essential care research partnerships, and funding more pioneering ways to transform the dementia landscape, 2024 has been the biggest year ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

2024 — A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Millions of people with overactive bladder syndrome are prescribed daily anticholinergics. But research has linked these ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...